Literature DB >> 11896082

The effect of fixation and processing on the sensitivity of oestrogen receptor assay by immunohistochemistry in breast carcinoma.

H Lee1, A G Douglas-Jones, J M Morgan, B Jasani.   

Abstract

AIMS: To investigate the effect of different fixation and processing regimens on the assessment of oestrogen receptor (ER) by immunohistochemistry (IHC).
METHODS: The ER results for 420 patients from seven different hospitals in which antigen retrieval and IHC were performed centrally were compared. The intensity of ER positivity was assessed semiquantitatively using the Quick score (range 0-7). The scoring profiles of cases from each different source (hospital) were compared to detect differences in the proportion of cases that were negative (Quick score = 0), moderately positive (Quick score = 1-5), and strongly positive (Quick score = 6-7).
RESULTS: There were no significant differences (p = 0.3; kappa(2) test) in the proportion of cases in each category.
CONCLUSIONS: None of the fixation or processing regimens had a significant adverse effect on the sensitivity of the ER assessment performed by automated immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896082      PMCID: PMC1769609          DOI: 10.1136/jcp.55.3.236

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

Review 1.  Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance.

Authors:  D M Barnes; R R Millis; L V Beex; S M Thorpe; R E Leake
Journal:  Eur J Cancer       Date:  1998-10       Impact factor: 9.162

2.  Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

3.  Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems.

Authors:  A Rhodes; B Jasani; D M Barnes; L G Bobrow; K D Miller
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

4.  Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.

Authors:  L P Pertschuk; J G Feldman; Y D Kim; L Braithwaite; F Schneider; A S Braverman; C Axiotis
Journal:  Cancer       Date:  1996-06-15       Impact factor: 6.860

5.  Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.

Authors:  D M Barnes; W H Harris; P Smith; R R Millis; R D Rubens
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

  5 in total
  8 in total

Review 1.  Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.

Authors:  Lokesh Agrawal; Kelly B Engel; Sarah R Greytak; Helen M Moore
Journal:  Semin Cancer Biol       Date:  2017-12-16       Impact factor: 15.707

2.  Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression.

Authors:  Anniina Raitila; Heli J Lehtonen; Johanna Arola; Elina Heliövaara; Manuel Ahlsten; Marianthi Georgitsi; Anu Jalanko; Anders Paetau; Lauri A Aaltonen; Auli Karhu
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

3.  Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study.

Authors:  C A Wells; J P Sloane; D Coleman; C Munt; I Amendoeira; N Apostolikas; J P Bellocq; S Bianchi; W Boecker; G Bussolati; C E Connolly; P Dervan; M Drijkoningen; I O Ellis; C W Elston; V Eusebi; D Faverly; P Heikkila; R Holland; J Jacquemier; M Lacerda; J Martinez-Penuela; C De Miguel; J L Peterse; F Rank; A Reiner; E Saksela; B Sigal-Zafrani; M Sylvan; B Borisch; G Cserni; T Decker; H Kerner; J Kulka; P Regitnig; A Sapino; A M Tanous; S Thorstenson; E Zozaya
Journal:  Virchows Arch       Date:  2004-06-24       Impact factor: 4.064

4.  Interstitial Cajal-like cells in human gallbladder.

Authors:  Mihail E Hinescu; Carmen Ardeleanu; Mihaela Gherghiceanu; Laurentziu M Popescu
Journal:  J Mol Histol       Date:  2007-05-31       Impact factor: 2.611

5.  Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells.

Authors:  M P Lewis; K A Lygoe; M L Nystrom; W P Anderson; P M Speight; J F Marshall; G J Thomas
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

Review 6.  Improving accuracy of breast cancer biomarker testing in India.

Authors:  Tanuja Shet
Journal:  Indian J Med Res       Date:  2017-10       Impact factor: 2.375

7.  Breast Cancer Reporting in Lagos, Nigeria: Implications for Training and Education in Africa.

Authors:  Adetola O Daramola; Adekunbiola A Banjo; Aneliese Bennett; Fatimah Abdulkareem; Abeer M Shaaban
Journal:  J Glob Oncol       Date:  2016-04-06

8.  Role of FGFR3 in Urothelial Carcinoma.

Authors:  Malik Akanksha; Sundaram Sandhya
Journal:  Iran J Pathol       Date:  2019-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.